Buy EYLEA Aflibercept 40mg/1ml Bayer Online
EYLEA Aflibercept 40mg/1ml is an effective medication developed by Bayer for the treatment of various eye disorders. It contains aflibercept, a recombinant fusion protein that targets VEGF A and PIGF that helps curb abnormal blood vessel growth, fluid leakage, and retinal damage. Initially approved for neovascular AMD treatment in November 2011, EYLEA has proven to be highly effective, reduces dependence on photodynamic therapy, and has a low incidence of non-ocular and ocular adverse effects. Apart from neovascular AMD, it has also been approved to treat DME and RVO in which clinical trials have shown significant improvement in visual acuity. EYLEA has several advantages over other anti-VEGF therapies, including a longer treatment interval, higher binding affinity for VEGF, and better safety in specific patient subgroups.
Buy Tyrvaya (varenicline solution) Online
DISEASE INDICATIONS: Dye Eye Disease MANUFACTURER: USAGE:Intravenous MEDICINE APPROVED BY: Therapeutic Goods Administration (TGA) Tyrvaya (varenicline solution) is a solution specifically designed as a nasal spray for the treatment of the symptoms and indications of dry eye disease.
Buy Vabysmo (faricimab-svoa) Online
DISEASE INDICATIONS: Macular Degeneration MANUFACTURER: Roche Registration Limited USAGE: Intravitreal MEDICINE APPROVED BY: Food and Drug Administration (FDA) Vabysmo (faricimab-svoa) is a prescribed medication utilized for managing two of the principal causes of visual impairment - neovascular or "wet" age-related macular degeneration (nAMD) and diabetic macular edema (DME).
Buy Xipere (triamcinolone acetonide injectable suspension) Online
DISEASE INDICATIONS: Macular Edema MANUFACTURER: Bausch + Lomb and Clearside Biomedical USAGE: Intravenous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Xipere (triamcinolone acetonide injectable suspension) is a medication that requires a doctor's prescription and is indicated for the management of uveitis-associated macular edema.